Literature DB >> 12968020

Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein.

Gunther Marsche1, Robert Zimmermann, Seikoh Horiuchi, Narendra N Tandon, Wolfgang Sattler, Ernst Malle.   

Abstract

The presence of HOCl-modified epitopes inside and outside monocytes/macrophages and the presence of HOCl-modified apolipoprotein B in atherosclerotic lesions has initiated the present study to identify scavenger receptors that bind and internalize HOCl-low density lipoprotein (LDL). The uptake of HOCl-LDL by THP-1 macrophages was not saturable and led to cholesterol/cholesteryl ester accumulation. HOCl-LDL is not aggregated in culture medium, as measured by dynamic light scattering experiments, but internalization of HOCl-LDL could be inhibited in part by cytochalasin D, a microfilament disrupting agent. This indicates that HOCl-LDL is partially internalized by a pathway resembling phagocytosis-like internalization (in part by fluid-phase endocytosis) as measured with [14C]sucrose uptake. In contrast to uptake studies, binding of HOCl-LDL to THP-1 cells at 4 degrees C was specific and saturable, indicating that binding proteins and/or receptors are involved. Competition studies on THP-1 macrophages showed that HOCl-LDL does not compete for the uptake of acetylated LDL (a ligand to scavenger receptor class A) but strongly inhibits the uptake of copper-oxidized LDL (a ligand to CD36 and SR-BI). The binding specificity of HOCl-LDL to class B scavenger receptors could be demonstrated by Chinese hamster ovary cells overexpressing CD36 and SR-BI and specific blocking antibodies. The lipid moiety isolated from the HOCl-LDL particle did not compete for cell association of labeled HOCl-LDL to CD36 or SR-BI, suggesting that the protein moiety of HOCl-LDL is responsible for receptor recognition. Experiments with Chinese hamster ovary cells overexpressing scavenger receptor class A, type I, confirmed that LDL modified at physiologically relevant HOCl concentrations is not recognized by this receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968020     DOI: 10.1074/jbc.M308428200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Whole tumor antigen vaccines.

Authors:  Cheryl Lai-Lai Chiang; Fabian Benencia; George Coukos
Journal:  Semin Immunol       Date:  2010-03-30       Impact factor: 11.130

2.  Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARgamma mRNA expression and modulates SR-BI gene expression in murine macrophages.

Authors:  Thomas Westendorf; Juergen Graessler; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

3.  Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state.

Authors:  Q Liu; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2005 Jul-Sep       Impact factor: 3.219

4.  Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.

Authors:  Gunther Marsche; Sasa Frank; Andelko Hrzenjak; Michael Holzer; Sabine Dirnberger; Christian Wadsack; Hubert Scharnagl; Tatjana Stojakovic; Akos Heinemann; Karl Oettl
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

Review 5.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

Review 6.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

7.  Effects of different LDL particles on inflammatory molecules in human mesangial cells.

Authors:  E Santini; R Lupi; S Baldi; S Madec; D Chimenti; E Ferrannini; A Solini
Journal:  Diabetologia       Date:  2008-08-28       Impact factor: 10.122

8.  Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.

Authors:  Stefan Porubsky; Holger Schmid; Mahnaz Bonrouhi; Matthias Kretzler; Ernst Malle; Peter J Nelson; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

9.  Protein carbamylation renders high-density lipoprotein dysfunctional.

Authors:  Michael Holzer; Martin Gauster; Thomas Pfeifer; Christian Wadsack; Guenter Fauler; Philipp Stiegler; Harald Koefeler; Eckhard Beubler; Rufina Schuligoi; Akos Heinemann; Gunther Marsche
Journal:  Antioxid Redox Signal       Date:  2011-03-28       Impact factor: 8.401

10.  Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein.

Authors:  Gunther Marsche; Bernd Weigle; Wolfgang Sattler; Ernst Malle
Journal:  FASEB J       Date:  2007-05-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.